%0 Journal Article
%T Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations
%A Chang-Min Choi
%A Ho Cheol Kim
%A Jae Cheol Lee
%A Shinkyo Yoon
%A Wonjun Ji
%A Yeh Rim Kang
%A Yeon Joo Kim
%J Archive of "OncoTargets and therapy".
%D 2019
%R 10.2147/OTT.S213928
%X BRAF mutations are found in 1¨C5% of non-small cell lung cancers, particularly adenocarcinomas. However, information regarding this mutation is limited in patients without EGFR/ALK aberrations, who have limited treatment options
%K BRAF
%K adenocarcinoma
%K lung cancer
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666367/